Selenoprotein biosynthesis machinery

The **selenoprotein biosynthesis machinery** refers to the specialized, evolutionarily conserved, multi-component cellular system that mediates the synthesis of selenoproteins—proteins characterized by the presence of the rare amino acid selenocysteine (Sec, the 21st genetically encoded amino acid)[1][2][3][4]. This machinery involves a coordinated network of enzymes, specialized tRNAs, elongation factors, and specific RNA elements (such as the SECIS element) that recognize UGA codons in mRNA as signals for selenocysteine insertion, not as stop codons. Key components include seryl-tRNA synthetase, phosphoseryl-tRNA kinase (PSTK), selenophosphate synthetase 2 (SPS2), and selenocysteine synthase (SecS), which work together to form and deliver Sec-tRNA^[Ser]Sec^ to the ribosome with the assistance of the translation elongation factor eEFSec and SECIS-binding protein 2 (SBP2)[3]. Defects or dysregulation of this machinery can cause systemic selenoprotein loss or deficiencies, contributing to various human diseases. The pathway is not a single protein or classic drug target, but rather a suite of interacting factors that determine organismal selenium utilization and selenoprotein production[3][5][6].

Other names

Selenocysteine biosynthesis pathwaySelenoprotein synthesis machinerySec biosynthesis pathway

Selenium supplementation provides substrate for machinery; modulation of biosynthetic enzyme activity could up- or down-regulate selenoprotein levels.